PARK7 and neurodegenerative disease: Additionally, the ClueGo interaction also suggested that other neurodegenerative disease-causing genes impact amyloid-associated pathways, such as LRRK2, PARK7, or SNCA. LRRK2 mutants were associated with reduced Aβ levels in patients with CSF of PD57.